By Maggie Fick BARCELONA (Reuters) – AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants,...
By Julie Zhu and Jane Xu HONG KONG (Reuters) – Chinese regulators are expected to fine Ant Group about a quarter less than the more than...
(Reuters) – Despite the second- and third-largest bank failures in U.S. history last month, the U.S. Federal Deposit Insurance Corporation remains on track to refill its...
SHANGHAI (Reuters) -Global automakers, including Toyota and Volkswagen, took the stage at the Shanghai auto show on Tuesday with built-for-China and electric-drive products to compete for...
By Mike Stone and Shivansh Tiwary (Reuters) -U.S. weapons maker Lockheed Martin Corp’s first-quarter results surpassed Wall Street targets on Tuesday despite parts and labor shortages,...
By Gabrielle Tétrault-Farber and Raghav Mahobe GENEVA (Reuters) -The World Health Organization’s chief called on Tuesday for the parties in the conflict in Sudan to provide...
By Emma Farge and Gabrielle Tétrault-Farber GENEVA (Reuters) -The International Federation of Red Cross and Red Crescent Societies said on Tuesday it was nearly impossible to...
By Natalie Grover and Aby Jose Koilparambil (Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as...
(Reuters) -Britain’s competition regulator said on Tuesday it has launched a “Phase 1” probe into Amazon.com Inc’s planned $1.7 billion acquisition of iRobot Corp, which makes...
By Foo Yun Chee and Supantha Mukherjee BRUSSELS/STOCKHOLM (Reuters) – The European Union agreed a 43-billion-euro ($47 billion) chip subsidies plan on Tuesday but the relatively...
Recent Comments